Science

Stephen Schoenberger: Remarkable Study on the Ontogeny of Neoantigen-Specific CD4+ T Cell Responses

Stephen Schoenberger/ lji.org

Sep 6, 2025, 16:14

Stephen Schoenberger: Remarkable Study on the Ontogeny of Neoantigen-Specific CD4+ T Cell Responses

Stephen Schoenberger, Professor at La Jolla Institute for Immunology, shared a post on LinkedIn, about a recent article by Ryan Q Griswold et al, adding:

“Proud to see Ryan Griswold’s superb work on the ontogeny of neoantigen-specific CD4+ T cell responses published in the Journal for ImmunoTherapy of Cancer – a remarkable and ground-breaking study.”

Title: The spontaneous neoantigen-specific CD4+ T-cell response to a growing tumor is functionally and phenotypically diverse

Authors: Ryan Q Griswold, Spencer E Brightman, Karla Soria Zavala, Manuel Azaid Ordaz-Arias, Navid Djassemi, Rukman R Thota, Martin S Naradikian, Hannah Dose, Suzie Alarcon, Pandurangan Vijayanand, Bjoern Peters, Aaron M Miller, Ezra E W Cohen, Stephen P Schoenberger

Read the Full Article on Journal for ImmunoTherapy of Cancer

Stephen Schoenberger: Remarkable Study on the Ontogeny of Neoantigen-Specific CD4+ T Cell Responses

More posts featuring CD4+ T cell.

Aaron M Miller Bjoern Peters cancer Ezra E. W. Cohen Hannah Dose Karla Soria Zavala Manuel Azaid Ordaz-Arias Martin S Naradikian Navid Djassemi OncoDaily Oncology Pandurangan Vijayanand Rukman R Thota Ryan Q Griswold Spencer E Brightman Stephen P Schoenberger Stephen Schoenberger Suzie Alarcon

Aparna Parikh Has Been Named Program Director for the GI Medical Oncology Program at Mass General Brigham

Herbert Loong: Grateful for the Journey with ASCO International Affairs Committee

Unreleased Decision Letters From 2024–2025 Now Available - FDA

Servier and IDEAYA Biosciences Partner to Advance Darovasertib for Uveal Melanoma

FDA Grants Breakthrough Therapy Designation to Zongertinib (HERNEXEOS) for First-Line Treatment of HER2-Mutant Advanced NSCLC